INSUBCONTINENT EXCLUSIVE:
Lupin, the country's second-largest drug maker by revenue, posted a 41.5 per cent fall in second-quarter profit on Wednesday, hurt by higher
earlier, Lupin said.Analysts on average had expected a profit of Rs 273 crore, according to Refintiv data.Income from operations rose
